Akari Therapeutics PLC (AKTX)
1.60
-0.04
(-2.14%)
USD |
NASDAQ |
May 10, 16:00
1.58
-0.02
(-1.25%)
After-Hours: 20:00
Akari Therapeutics Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
DBV Technologies SA | 6.767M |
Cellectis SA | 82.86M |
Adaptimmune Therapeutics PLC | 0.88M |
Biodexa Pharmaceuticals Plc | 12.76M |
NuCana PLC | -0.0659M |